Nick H, Hofsteenge J, Shaw E, Rovelli G, Monard D
Friedrich Miescher Institute, Basel, Switzerland.
Biochemistry. 1990 Mar 6;29(9):2417-21. doi: 10.1021/bi00461a027.
Glia-derived nexin (GDN) is a 43-kDa serine protease inhibitor with neurite promoting activity in mouse neuroblastoma cells (Guenther et al., 1985). In chick sympathetic neurons, GDN but not hirudin and synthetic peptide inhibitors promoted neurite outgrowth (Zurn et al., 1988). Thus, it was considered that the protease inhibitory activity cannot account for the total biological activity of GDN. We show here that synthetic peptide inhibitors with thrombin specificity mimic GDN at similar concentrations in neuroblastoma cells. Limited proteolysis of GDN with elastase causes a cleavage between sites P1 and P2, corresponding to residues Ala-344-Arg-345 of the molecule. The resulting fragments still copurify on heparin-Sepharose, but the protease inhibitor activity of GDN and the GDN neurite promoting activity are lost. The results confirm the necessity of an intact reactive site for the biological activity of GDN.
神经胶质衍生的神经毒素(GDN)是一种43 kDa的丝氨酸蛋白酶抑制剂,对小鼠神经母细胞瘤细胞具有促进神经突生长的活性(Guenther等人,1985年)。在鸡交感神经元中,GDN而非水蛭素和合成肽抑制剂可促进神经突生长(Zurn等人,1988年)。因此,人们认为蛋白酶抑制活性不能解释GDN的全部生物学活性。我们在此表明,具有凝血酶特异性的合成肽抑制剂在神经母细胞瘤细胞中以相似浓度模拟GDN。用弹性蛋白酶对GDN进行有限的蛋白水解会导致在P1和P2位点之间发生切割,对应于该分子的Ala-344-Arg-345残基。所得片段仍可在肝素-琼脂糖凝胶上共纯化,但GDN的蛋白酶抑制活性和GDN促进神经突生长的活性丧失。结果证实了完整的反应位点对于GDN生物学活性的必要性。